Could NfL accelerate drug development for neurodegenerative diseases?
Drug Discovery World
OCTOBER 31, 2023
Professor Andy Whiting and Dr Tony Lockett discuss how specific levels of a protein could be used to advance drug development in neurodegenerative diseases. Neurofilament light (NfL) analysis is a potential biomarker for damage to both the central and peripheral nervous system. It has been used experimentally in international trials 1 , but researchers are hopeful that further use and evaluation in the UK will accelerate drug development for hard-to-treat neurodegenerative diseases.
Let's personalize your content